Thalassemia Market - Global Industry Analysis, Size, Share, Trends, Growth, and Forecasts, 2021 - 2031
Thalassemia Market – Overview
The global thalassemia market is projected to grow at a favorable rate from 2021 to 2031 (forecast period). The expanding population, increased need for improved curative gene treatments, and increased awareness of existing treatment choices are the primary aspects expected to drive the worldwide thalassemia market during the forecast period. As per the World Health Organization (WHO), thalassemia affects around 4.4 out of every 10,000 live births worldwide. Moreover, around 5% of the world's population has a polymorphism in the beta or alpha region of the hemoglobin molecule. Furthermore, an increase in the development of pipeline pharmaceuticals and innovative therapeutics, together with research and development, is projected to boost the global thalassemia market.
In addition, rising investments in the healthcare sector are likely to create revenue-generation opportunities in thalassemia market throughout the forecast period.
Thalassemia Market – Competitive Landscape
Leading players in the thalassemia market are Bluebird Bio, Novartis AG, Bellicum Pharmaceuticals, Acceleron Pharma, Inc., ApoPharma Inc, IONIS Pharmaceuticals, SG Pharma Pvt. Lmt, Kiadis Pharma, and Lonza Group Ltd.
Market players are adopting marketing methods such as technological developments, collaborations, acquisitions, investments, and R&D activities to widen their international presence. Moreover, several innovative gene treatments with improved mechanisms of action are now in late-stage studies to meet the significant unmet demand for thalassemia therapy.
Thalassemia Market – Trends and Opportunities
The global thalassemia market is expected to gain from a spike in the number of clinical trials for thalassemia treatment alternatives. Moreover, the increase in thalassemia prevalence and the development of thalassemia pipeline drugs are projected to fuel the thalassemia market growth. Furthermore, factors such as the expanding market for blood transfusion therapy and bone marrow transplant, an uptick in the number of transfusion-dependent patients, and the development of accessible therapeutic solutions for thalassemia are anticipated to boost the global thalassemia market.
In addition, an upsurge in healthcare spending, a rise in demand for improved curative gene therapy, and an increase in expenditure on stem cell therapy research are some of the main factors expected to promote the growth of the thalassemia market during the forecast period.
The hospital segment is projected to witness significant growth in the worldwide thalassemia market during the forecast period. This is mostly due to an increase in hospital admissions for thalassemia therapy. Moreover, the increased incidence of thalassemia is expected to fuel segmental market growth. The labs segment, on the other hand, is likely to experience considerable growth during the projection period due to rising public awareness of thalassemia therapy.
Thalassemia Market – Regional Landscape
The North America thalassemia market is anticipated to develop during the forecast period. The high incidence of thalassemia patients in the area, the existence of prominent players, and the developed healthcare infrastructure are some of the key reasons expected to boost the regional market growth. Moreover, positive government efforts and a rise in the number of research collaborations are likely to fuel market expansion. The United States is projected to be the largest revenue generator in thalassemia market due to increased knowledge of the disorder, a growing number of populations with the thalassemia carrier gene, and an increase in birth rates due to genetic heterogeneity within the population.
The thalassemia market in Asia Pacific is likely to expand during the forecast period. The rising number of thalassemia patients and higher government spending on the healthcare system are the primary factors anticipated to propel the regional market in the upcoming years. Moreover, developing countries such as China and India are expected to contribute to the thalassemia market in Asia Pacific during the forecast period.
The reports at TMR Research provide qualitative solutions that break the barriers of doubt or uncertainties when the stakeholders plan to expand their growth reach. The researchers compile the necessary information that enlightens the CXOs about the current growth opportunities in a specific market and enables them to make the most of the opportunities.
TMR Research is a leader in developing well-researched reports. The expertise of the researchers at TMR Research makes the report stand out from others. TMR Research reports help the stakeholders and CXOs make impactful decisions through a unique blend of innovation and analytical thinking. The use of innovation and analytical thinking while structuring a report assures complete and ideal information of the current status of the market to the stakeholders.
TMR Research has rich experience in developing state-of-the-art reports for a wide array of markets and sectors. The brilliance of the experts at TMR Research and their alacrity to conduct thorough research and create phenomenal reports makes TMR Research better than others.
5-Point Growth Formula
The 5-point growth formula developed by TMR Research provides an insight to the stakeholders and CXOs about the current situation in the market. The growth formula makes the report a perfect companion for the stakeholders and CXOs.
The 5-point growth formula includes the following points:
Current and Future Threats
Along with studying the opportunities necessary for growth, threats are also an important aspect to look upon for the companies and stakeholders in a specific sector. TMR Research studies every negative aspect that will hinder the growth of a specific area of business and includes it in the report. The stakeholders and CXOs will have the benefit of assessing the threat and take the necessary steps to prevent the hindrance caused due to the threats.
Accurate Trend Analysis
Keeping up with the latest trends is crucial in any business or sector. While stakeholders are aware of the trends that are on the surface, TMR Researchers find trends that are deeply entrenched in the particular market or sector. The reports are constantly updated with the latest trends so that the stakeholders and CXOs can derive benefits from the trends and generate good revenues.
Demography forms an important part of the growth pattern of all the markets. Diving deep into the demographics enables maximum output from specific areas. The TMR Research team assesses every region and picks out the vital points that have a large impact on the growth of a market.
The analysts at TMR Research conduct an all-round analysis on the competitive landscape of the market. The observations recorded by the analysts are added to the reports so that every stakeholder gets a glimpse of the competitive scenario and frame their business plans according to the situation.
The COVID-19 outbreak has changed the growth projections of numerous sectors and businesses. The analysts at TMR Research have conducted a conscientious survey on the markets after the pandemic struck. The analysts have put forth their brilliant and well-researched opinions in the report. The opinions will help the stakeholders to plan their strategy accordingly.
The reports offer answers to the top 7 questions that revolve around the growth of the market
Flat 10% discount on Single User License if you prebook this report
Flat 10% discount on Multiple User License if you prebook this report
Flat 10% discount on Corporate License if you prebook this report